StonvexLoading…
StonvexStonvexStonvexCore line items from JVA's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-01-31 | Annual 2025 2025-10-31 | Q3 2025 2025-07-31 | Q2 2025 2025-04-30 |
|---|---|---|---|---|
Revenue | $25.57M | $96.28M | $68.54M | $44.63M |
Operating Income | $2.38M | $2.15M | $1.38M | $2.48M |
Net Income | $1.65M | $1.40M | $591.90K | $644.05K |
EPS (Diluted) | $0.29 | $0.25 | $0.10 | $0.31 |
Total Assets | $41.15M | $42.05M | $45.88M | $39.73M |
Total Liabilities | $12.39M | $14.47M | $19.11M | $11.75M |
Cash & Equivalents | $2.75M | $701.87K | $979.77K | $1.83M |
Free Cash Flow OCF − CapEx | $6.58M | $-5.21M | $-5.48M | $-1.59M |
Shares Outstanding | 5.71M | 5.71M | 5.71M | 5.71M |